| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21AI190856 | Characterization of two virulence-associated S. aureus sRNAs | 000 | 2 | NIH | 10/15/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $62,300,151 ) (Continued on the next page) |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI186314 | Hydrogel-based lymphoid tissues for generation of activated human B cells and delivery in vivo | 000 | 3 | NIH | 6/19/2026 | $750,322 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00NS123233 | Spatial and temporal regulation of synapse formation through phase separation | 000 | 5 | NIH | 7/9/2026 | $240,735 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 000 | 5 | NIH | 1/29/2026 | $424,391 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 001 | 5 | NIH | 4/16/2026 | $47,154 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI181282 | Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells | 000 | 3 | NIH | 6/9/2026 | $213,516 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI181282 | Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells | 000 | 3 | NIH | 6/9/2026 | $520,844 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM152121 | Biochemistry of membrane proteins involved in lipid and cannabinoid metabolism | 000 | 3 | NIH | 7/8/2026 | $371,909 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA273878 | Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells | 000 | 4 | NIH | 5/18/2026 | $655,363 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM153457 | Domesticating and Mapping Interactions of the Human Gastrointestinal Microbiome | 000 | 3 | NIH | 4/10/2026 | $370,744 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM150876 | Disentangling Sugar Signaling in Plants | 000 | 4 | NIH | 5/26/2026 | $381,781 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI182322 | Microscale Multiplexed Antibody Fc Profiling and Nanoscale Electronic Detection for Rapid and Scalable Point-of-Care Diagnosis of Tuberculosis | 000 | 3 | NIH | 5/20/2026 | $382,775 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM149286 | Systems Biology to Unlock the Next Level of Cell-Free Synthetic Biology | 000 | 4 | NIH | 8/25/2026 | $395,500 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL175067 | Mechanosensing in lung fibrosis | 000 | 3 | NIH | 6/10/2026 | $512,587 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI168408 | Engineering Protein Antigens and their Presentation from Multivalent Scaffolds | 000 | 4 | NIH | 6/9/2026 | $789,654 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32EY036268 | The Structural and Biochemical Effects of XFG-Associated Variants in LOXL1 | 000 | 3 | NIH | 8/24/2026 | $81,580 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174122 | Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | 000 | 3 | NIH | 5/12/2026 | $50,114 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01GM148586 | Elucidating the mechanisms of protein secretion across the outer membrane by bacterial autotransporters | 000 | 4 | NIH | 8/28/2026 | $396,261 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AR083702 | Bactericidal hydrogels for bone repair | 000 | 3 | NIH | 5/19/2026 | $486,779 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | NU2RGH001919 | Informing global polio eradication efforts through innovative modeling approaches | 00 | 5 | CDC | 9/15/2026 | $250,000 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90AREM0006 | ARRT - Employment Across Evolving Work Programs | 01 | 4 | ACL | 8/4/2026 | $0 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90AREM0006 | ARRT - Employment Across Evolving Work Programs | 00 | 4 | ACL | 6/10/2026 | $199,996 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AG073250 | Influences of Environmental Geometry and Aging on Cognitive Mapping Mechanisms | 000 | 5 | NIH | 4/28/2026 | $436,091 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM145350 | Illuminating Heme Trafficking and Signaling Pathways in Health and Disease | 000 | 5 | NIH | 2/27/2026 | $374,712 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB038279 | Combined IVUS/FFR microcatheter for guiding complex percutaneous coronary interventions | 000 | 1 | NIH | 3/26/2026 | $603,818 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EB033580 | Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer | 002 | 5 | NIH | 2/19/2026 | $25,386 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL184139 | SCH: Advancing Public Health Intervention with Data-driven Restless Multi-Armed Bandit Framework | 000 | 2 | NIH | 8/5/2026 | $293,997 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL187527 | Hydrogel delivery of stem cells to dystrophic diaphragm | 000 | 1 | NIH | 9/17/2026 | $736,461 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB039036 | Robotic Ultrasound-Mediated Thrombectomy for First Pass Stroke Treatment | 001 | 1 | NIH | 9/3/2026 | $0 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | RF1MH140429 | Multiscale Models for Understanding Multi-Animal Interactions and Intent | 000 | 1 | NIH | 3/9/2026 | $2,596,724 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB039036 | Robotic Ultrasound-Mediated Thrombectomy for First Pass Stroke Treatment | 000 | 1 | NIH | 8/28/2026 | $625,554 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL183894 | Improved treatment of intramural ventricular arrhythmia using robot-assisted MRI-guided intramyocardial needle ablation | 000 | 1 | NIH | 9/3/2026 | $808,511 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90DPCP0016 | ACCESS for Aging Well with AT (Aging Well 2.0): An Integrated Platform for Assessments and Solutions for Independent Living Outcomes | 00 | 1 | ACL | 9/29/2026 | $499,993 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01NS132288 | Tracking Flow of Attention in Visual Circuits Across the Brain | 000 | 2 | NIH | 9/9/2026 | $393,903 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21TR005579 | Improving Bronchoalveolar Lavage To Enhance Diagnostic Yield Of Pulmonary Complications | 000 | 1 | NIH | 4/28/2026 | $416,231 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA315100 | Mapping and Manipulating Cancer-Associated Neuronal Networks | 000 | 1 | NIH | 8/6/2026 | $523,554 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM161177 | Harnessing Biomolecular Simulations to Understand Protein Dynamics and Allostery | 000 | 1 | NIH | 5/19/2026 | $432,850 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2601GAATSG | FY2026 (ATSG) AT Act State Grants for Assistive Technology | 0 | 1 | ACL | 12/10/2025 | $240,532 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2601GAATSG | FY2026 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 3/27/2026 | $472,840 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM162583 | Cellular basis of complex behavior | 000 | 1 | NIH | 5/14/2026 | $407,283 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21AG102510 | Human Aged-Immunity-on-Chip to Study B Cell Dynamics | 000 | 1 | NIH | 8/21/2026 | $432,849 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AR087123 | Optimizing fluorescent nanoparticle-based motion capture to understand the neural control of movement in health and disease | 000 | 1 | NIH | 8/21/2026 | $453,560 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM166073 | Gut protist metabolism as a driver of microbiome community ecology | 000 | 1 | NIH | 8/24/2026 | $393,500 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21CA309231 | Synergistic blood-brain barrier indoximod delivery and selective treatment of malignant glioma using Pulsed Field Ablation | 000 | 1 | NIH | 7/7/2026 | $396,457 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00DK139418 | New siRNA therapeutics to halt diabetic kidney disease | 000 | 3 | NIH | 4/17/2026 | $248,999 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM166288 | Biointerface quantum and nanosensing technologies to investigate autophagic pathways | 000 | 1 | NIH | 7/27/2026 | $421,857 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI195271 | Controlled Delivery of Adjuvanted Multivalent Fusion Peptide Focused HIV Vaccines | 000 | 1 | NIH | 1/28/2026 | $725,241 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32AI200531 | Uncovering how protists shape gut microbiome function and community structure | 001 | 1 | NIH | 6/10/2026 | $0 |
|
